Workflow
Seres Therapeutics cuts 25% of workforce to extend cash runway into Q2 2026

Group 1 - Seres Therapeutics plans to reduce operating costs and cut its workforce by approximately 25% [1] - These measures, along with current operating plans, are expected to extend the company's cash runway into the second quarter of 2026 [1]